Patents Assigned to Merck Patent GmbH
  • Compounds and organic electronic devices
    Patent number: 11258018
    Abstract: The present invention relates to certain fluorenes, to the use of the compounds in an electronic device, and to an electronic device comprising at least one of these compounds. The present invention furthermore relates to a process for the preparation of the compounds and to a formulation and composition comprising one or more of the compounds.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: February 22, 2022
    Assignee: Merck Patent GmbH
    Inventors: Teresa Mujica-Fernaud, Elvira Montenegro, Amir Parham, Arne Buesing, Frank Voges
  • Liquid-crystalline medium and high-frequency components comprising same
    Patent number: 11254874
    Abstract: The present invention relates to liquid-crystalline media comprising one or more chiral compounds and one or more compounds selected from the group of compounds of formulae I, II and III, in which the parameters have the meaning indicated in claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: February 22, 2022
    Assignee: Merck Patent GmbH
    Inventors: Michael Wittek, Dagmar Klass
  • Crosslinking p-dopants for p-doping organic hole conductors
    Patent number: 11258020
    Abstract: A method produces cross-linked hole-conducting electric layers by converting functionalized p-dopants. The functionalized p-dopants are organic metal complexes containing at least one central atom and organic ligands, wherein the central atom is selected from a metal of the groups 6-15 of the periodic table, and at least one of the organic ligands is selected from the following formulas I-V, in which E independently of one another is oxygen, sulfur, selenium, or N(E1)x, and each Rv has at least one functionalizing group selected from the group RF including —OH, —COOH, —NH2, —NHR?, halogen, C2-C40-alkenyl, -dienyl, -alkinyl, -alkenyloxy, -dienyloxy, -alkinyloxy, acrylic acid, oxetan, oxiran, silane, acrylic acid, anhydride, and cyclobutane or consists of the groups, and G=C(RF)uHvFw where u+v+w=3 and n=1-4.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: February 22, 2022
    Assignees: OSRAM OLED GmbH, MERCK Patent GmbH
    Inventors: Günter Schmid, Florian Kessler, Katja Stegmaier, Fabrice Eckes, Holger Heil, Beate Burkhart, Henning Seim
  • Liquid crystal media comprising polymerisable compounds
    Patent number: 11254872
    Abstract: Liquid crystal (LC) media comprising polymerisable compounds as further specified in the description and claims and a self-alignment additive for vertical alignment. The media are adapted for use in LC displays, especially in LC displays of the polymer-sustained alignment type.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: February 22, 2022
    Assignee: Merck Patent GmbH
    Inventors: Helmut Haensel, Steffen Gnauck, Qiong Tong, Sabrina Zeiss
  • Combination of a protein kinase inhibitor and an additional chemotherapeutic agent
    Patent number: 11246929
    Abstract: Combination therapy for the treatment of cancer.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: February 15, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Lars Damstrup, Thomas Grombacher, Christian Sirrenberg, Lyubomir Vassilev, Astrid Zimmermann
  • Polymerisable LC medium and polymer film with flat optical dispersion
    Patent number: 11248171
    Abstract: The invention relates to a polymerisable LC medium with flat optical dispersion, a polymer film with flat optical dispersion obtainable from such a medium, and the use of the polymerisable LC medium and polymer film in optical, electro optical, electronic, semiconducting or luminescent components or devices.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: February 15, 2022
    Assignee: Merck Patent GmbH
    Inventors: Eduardo Beltran Gracia, Iain Gardiner, Rebecca Proctor, Stephen Mulcahy
  • Particle size and distribution of polymer for melt extrusion application
    Patent number: 11246935
    Abstract: An extrudable polyvinyl alcohol (PVA) powder with improved flowability containing particles of PVA, which has been cryo-milled, and which has d50 particle sizes in the range of 45 to 1400 ?m; or which has a particle size distribution of d10=20±10 ?m, d20=30±10 ?m, d50=70±10 ?m, d90=200±30 ?m, and d99=300±30 ?m; and a powdery composition for the preparation of pharmaceutical formulations which contains the polyvinyl alcohol homogeneously mixed with at least one active pharmaceutical ingredient (API); and a process for producing a solid pharmaceutical dosage form by extruding or forming a homogeneous melt of a mixture of ingredients containing the powdered polyvinyl alcohol and at least one active pharmaceutical ingredient (API), and forming a powder or a molded form.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: February 15, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Dieter Lubda, Mengyao Zheng, Nicole Di Gallo, Anja-Nadine Knuettel
  • Method for producing fluorinated compounds
    Patent number: 11247960
    Abstract: The present invention relates to a process for the preparation of fluorinated compounds, to novel compounds containing fluorinated end groups, to the use thereof and to compositions comprising novel compounds containing fluorinated end groups.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: February 15, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Reiner Friedrich, Fabian Koch
  • PROCESS FOR THE PREPARATION OF A COATED SOLID PHARMACEUTICAL DOSAGE FORM
    Publication number: 20220040917
    Abstract: The present invention is directed to a process for the preparation of a coated solid pharmaceutical dosage form using 3D printing technology.
    Type: Application
    Filed: September 12, 2019
    Publication date: February 10, 2022
    Applicant: MERCK PATENT GMBH
    Inventors: Malte BOGDAHN, Stefan SCHILLER, Andrea HANEFELD, Simon GEISSLER
  • ELECTROLUMINESCENT DEVICES
    Publication number: 20220045277
    Abstract: The present invention describes electronic devices and compositions that can be used in electronic devices.
    Type: Application
    Filed: September 12, 2019
    Publication date: February 10, 2022
    Applicant: Merck Patent GmbH
    Inventors: Ilona STENGEL, Antonia MORHERR, Falk MAY, Aaron LACKNER, Christof PFLUMM, Amel MEKIC, Nils HAASE
  • Materials for organic electroluminescent devices
    Patent number: 11245079
    Abstract: The invention relates to compounds which are suitable for use in electronic devices, and electronic devices, in particular organic electroluminescent devices, containing said compounds.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: February 8, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Anja Jatsch, Tobias Grossmann, Amir Hossain Parham, Thomas Eberle, Christof Pflumm, Jonas Kroeber, Philipp Stoessel, Elvira Montenegro, Rouven Linge
  • POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM
    Publication number: 20220033711
    Abstract: The invention relates to a polymerisable LC material comprising one or more di- or multireactive mesogenic compounds and one or more compounds of formula UVI, wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film with improved thermal durability and UV stability obtainable from a corresponding polymerisable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerisable LC material for optical, electro-optical, decorative or security devices.
    Type: Application
    Filed: November 29, 2019
    Publication date: February 3, 2022
    Applicant: MERCK PATENT GMBH
    Inventors: Yong-Hyun CHOI, Jae-Hyun KANG, Hyun-Jin YOON
  • Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof
    Patent number: 11235063
    Abstract: A heterodimeric bispecific immunoglobulin molecule includes a first Fab or scFv fragment which specifically binds to EGFR, and a second Fab or scFv fragment which specifically binds to c-MET, and an antibody hinge region, an antibody CH2 domain and an antibody CH3 domain including a hybrid protein-protein interaction interface domain. Each of the interaction interface domains is formed by an amino acid segment of the CH3 domain of a first member and an amino acid segment of the CH3 domain of a second member. The hybrid protein-protein interface domain of the first chain is interacting with the protein-protein-interface of the second chain by homodimerization of a corresponding amino acid segment of the same member of the immunoglobulin superfamily within interaction domains.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: February 1, 2022
    Assignee: Merck Patent GmbH
    Inventors: Achim Doerner, Lars Toleikis, Vanita D. Sood, Carolin Sellmann, Christine Knuehl
  • Dibenzofuran derivatives and dibenzothiophene derivatives
    Patent number: 11236063
    Abstract: Compounds of the formula I in which groups and parameters that occur have the definitions given in the disclosure. Preparation methods for these compounds. Uses of the compounds as components in liquid-crystalline media. Electrooptical display elements comprising the liquid-crystalline media.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: February 1, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Lars Lietzau, Achim Goetz, Harald Hirschmann, Martin Engel
  • Liquid-crystal media and light modulation element
    Patent number: 11236271
    Abstract: The present invention relates to liquid crystalline (LC) medium, to a method of its production and to the use of such LC media in polymer network liquid crystalline (PNLC) light modulation elements operated in the normally transparent mode. Furthermore, the present invention relates to such light modulation elements, as such, to the use of such light modulation elements as light shutters for transparent OLED displays, to the use of such light modulation elements in smart windows, and to a method of production of such light modulation elements according to the present invention.
    Type: Grant
    Filed: September 4, 2017
    Date of Patent: February 1, 2022
    Assignee: Merck Patent GmbH
    Inventors: Dong-Mee Song, Hyun-Woo Bae, Jung-Min Lee, Yong-Kuk Yun
  • Monosubstituted urea derivatives as a self-tanning substance
    Patent number: 11234914
    Abstract: The present invention relates to the use of monosubstiuted urea derivatives of the formula I as self-tanning substance, for increasing melanin synthesis, for improving melanin transport and/or improving the distribution of melanin in suprabasal layers, and to preparations comprising these urea derivatives.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: February 1, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Julian Osthoff, Hansjuergen Driller, Christophe Carola, Robin Back, Michael Krohn
  • LIQUID-CRYSTALLINE MEDIUM
    Publication number: 20220025265
    Abstract: A liquid-crystalline media having a negative dielectric anisotropy and a high clearing point as specified herein, is suitable for use of in switchable optical cells in window elements, in particular laminated window elements.
    Type: Application
    Filed: July 15, 2021
    Publication date: January 27, 2022
    Applicant: Merck Patent GmbH
    Inventors: Hoo-Yong LEE, Hyun-Jin YOON
  • SWITCHABLE WINDOW ELEMENT
    Publication number: 20220026770
    Abstract: A switchable window element (10) having a layer structure is proposed. The layer structure comprises a switchable layer (20), two polarizers and two optical retarders, wherein a first polarizer and a first optical retarder are arranged in an optical path (40) prior to the switchable layer (20) and a second polarizer and a second optical retarder are arranged in the optical path (40) after the switchable layer (20). Further, the switchable layer (20) is a vertically aligned liquid crystal layer comprising a liquid crystalline medium, wherein the product of the thickness d of the switchable layer (20) and the optical anisotropy ?n of the liquid crystalline medium is in the range of from 0.05 ?m to 3.0 ?m and the liquid crystalline medium has a clearing point of at least 70° C. Further aspects of the invention relate to the use of the switchable window element as window for a building or a vehicle.
    Type: Application
    Filed: December 11, 2019
    Publication date: January 27, 2022
    Applicant: Merck Patent GmbH
    Inventors: Michael JUNGE, Andreas BEYER
  • Methods of atomic layer deposition for selective film growth
    Patent number: 11230764
    Abstract: Methods of forming metal-containing films by atomic layer deposition are provided. The methods include delivering a metal-containing complex, a purge gas, and a co-reactant to a first substrate under sufficient conditions such that the metal-containing film selectively grows on at least a portion of the first substrate.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: January 25, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Jean-Sébastien Lehn, Charles Dezelah, Jacob Woodruff
  • Process for the manufacture of a solid pharmaceutical administration form
    Patent number: 11229577
    Abstract: The present invention relates to a process for the preparation of a solid pharmaceutical administration form using a 3D printing process as well. The process is a printing process that allows the production of solid pharmaceutical administration forms in a flexible manner and in conformity with the high quality standards required for the production of pharmaceuticals.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: January 25, 2022
    Assignee: Merck Patent GmbH
    Inventors: Stefan Schiller, Andrea Hanefeld, Gerhard Jonschker